Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

July Deadline For EMA Relocation Bids; Member States Begin Scrutiny Of Proposed Hosting Criteria

Executive Summary

The criteria that candidates seeking to host the European Medicines Agency post-Brexit will have to meet are out for discussion among member state representatives and should be finalized towards the end of June. Formal bids will have to be in by July end and a decision on the EMA’s new home should be made in October.

You may also be interested in...



Criteria Out For EMA’s Future Home; Bid Procedure About To Be Approved

The procedure allowing EU member states to bid to host the European Medicines Agency when it leaves the UK is to be formally endorsed by a meeting of heads of state on June 22. The criteria countries will have to meet have been publicly announced at a press conference following a meeting of EU ministers.

Stability Or Chaos? UK Election Result Increases The Uncertainty For Pharma

UK industry bodies have expressed concern over the result of the UK general election, as the prime minister decides to form a minority government and EU officials say Brexit talks could be delayed.

My City’s Better Than Your City – The PR Offensive For The Post-Brexit EMA

How much information is too much? We take a look at some of the claims being made by cities keen to host the European Medicines Agency when it relocates from London.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS120716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel